Both CD4 + and CD8 + T-cells in HCC displayed a reduced capacity for IFNγ production, and BTLA blockade restored IFNγ production, suggesting the potential role of BTLA in suppressing effector functions of T-cells in HCC [82]. The gene discussed is CD4; the disease is hepatocellular carcinoma.